The Pleiotropic Effects of miRNAs on Tumor Angiogenesis

Journal of Cellular Biochemistry

Volumn 116, Issue 9, 2015, Pages 1807-1815

  Yin, Runting ^a,b   Guo, Le ^c   Zhang, Wei ^a   Zheng, Junnian ^b  

^a NANTONG UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

ANGIOGENESIS; CANCER; miRNAs

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; BIOLOGICAL MARKER; MICRORNA; MICRORNA 126; MICRORNA 130A; MICRORNA 17 92; MICRORNA 221; MICRORNA 222; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER THERAPY; EXOSOME; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HYPOXIA; METASTASIS; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR GROWTH; VENULE; GENE EXPRESSION REGULATION; GENETICS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84937510022     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24679     Document Type: Article

References (124)

1. Adams RH, Alitalo K,. 2007. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8: 464-478.
2. Aicher A, Zeiher AM, Dimmeler S,. 2005. Mobilizing endothelial progenitor cells. Hypertension 45: 321-325.
3. Akao Y, Nakagawa Y, Naoe T,. 2006. Let-7 MicroRNA Functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906.
4. Alaiti MA, Ishikawa M, Masuda H, Simon DI, Jain MK, Asahara T, Costa MA,. 2012. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis. J Cell Mol Med 16: 2413-2421.
5. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA,. 2010. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16: 909-914.
6. Barh D, 2008. Let-7 replacement therapy: Applicability in cancer. Cancer Ther 6: 969-984.
7. Bartel DP, 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ,. 2003. Dicer is essential for mouse development. Nat Genet 35: 215-217.
9. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G,. 2011. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108: 3713-3718.
10. Boll K, Reiche K, Kasack K, Morbt N, Kretzschmar AK, Tomm JM, Verhaegh G, Schalken J, von Bergen M, Horn F, Hackermuller J,. 2012. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 32: 277-285.
11. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S,. 2009. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713.
12. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, Adnot S, Maitre B,. 2000. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 279: L371-L378.
13. Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M,. 2011. MicroRNAs as a potential prognostic factor in gastric cancer. World J gastroenterol 17: 3976-3985.
14. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L,. 2010. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78: 838-848.
15. Carmeliet P, 2003. Angiogenesis in health and disease. Nat Med 9: 653-660.
16. Cha ST, Chen PS, Johansson G, Chu CY, Wang MY, Jeng YM, Yu SL, Chen JS, Chang KJ, Jee SH, Tan CT, Lin MT, Kuo ML,. 2010. MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res 70: 2675-2685.
17. Chan YC, Khanna S, Roy S, Sen CK,. 2011. MiR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells. J Biol Chem 286: 2047-2056.
18. Chang S-H, Hla T,. 2011. Gene regulation by RNA binding proteins and microRNAs in angiogenesis. Trends Mol Med 17: 650-658.
19. Chaput N, Théry C,. 2011. Exosomes: Immune properties and potential clinical implementations. Semin Immunopathol 33: 419-440.
20. Chen W-X, Hu Q, Qiu M-T, Zhong S-L, Xu J-J, Tang J-H, Zhao J-H,. 2013. MiR-221/222: Promising biomarkers for breast cancer. Tumor Biol 34: 1361-1370.
21. Chen Y, Gorski DH,. 2008. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HO XA5. Blood 111: 1217-1226.
22. Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB,. 2004. Adhesion and signaling by B cell-derived exosomes: The role of integrins. FASEB J 18: 977-979.
23. De Val S, Black BL,. 2009. Transcriptional control of endothelial cell development. Dev Cell 16: 180-195.
24. Denekamp J, 1982. Endothelial cell proliferation as a novel approach to targeting tumour therapy. Brit J Cancer 45: 136-139.
25. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF,. 2010. MicroRNA-222 Controls neovascularization by regulating signal transducer and activator of transcription 5a expression. Arterioscler Thromb Vasc Biol 30: 1562-1568.
26. Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, Urbich C, Hofmann WK, Zeiher AM, Dimmeler S,. 2010. Members of the microRNA- 17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 115: 4944-4950.
27. Doench JG, Sharp PA,. 2004. Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511.
28. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R,. 2008. MiR-148 targets human DNMT3b protein coding region. RNA 14: 872-877.
29. Ekström K, Valadi H, Sjöstrand M, Malmhäll C, Bossios A, Eldh M, Lötvall J,. 2012. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles 1: 10.3402/jev.v1i0 18389.
30. Eldh M, Ekstrom K, Valadi H, Sjostrand M, Olsson B, Jernas M, Lotvall J,. 2010. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS ONE 5: e15353.
31. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F,. 2008. MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3. J Biol Chem 283: 15878-15883.
32. Fevrier B, Raposo G,. 2004. Exosomes: Endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16: 415-421.
33. Filipowicz W, Bhattacharyya SN, Sonenberg N,. 2008. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?. Nat Rev Genet 9: 102-114.
34. Fish JE, Santoro MM, Morton SU, Yu S, Yeh R-F, Wythe JD, Ivey KN, Bruneau BG, Stainier DYR, Srivastava D,. 2008. MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
35. Flamme I, Frölich T, Risau W,. 1997. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173: 206-210.
36. Folkman J, 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-30.
37. Forman JJ, Legesse-Miller A, Coller HA,. 2008. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 105: 14879-14884.
38. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF,. 2005. MicroRNAs Regulate Brain Morphogenesis in Zebrafish. Science 308: 833-838.
39. Gordan JD, Simon MC,. 2007. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17: 71-77.
40. Grundmann S, Hans FP, Kinniry S, Heinke J, Helbing T, Bluhm F, Sluijter JPG, Hoefer I, Pasterkamp G, Bode C, Moser M,. 2011. Microrna-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells/clinical perspective. Circulation 123: 999-1009.
41. Guo C-J, Pan Q, Li D-G, Sun H, Liu B-W,. 2009. MiR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol 50: 766-778.
42. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ,. 2008. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105: 1516-1521.
43. He L, 2007. He Lab. microRNAs in cancer biology-small RNAs with a big impact. Research Molecular and Cell Biology. University of California Berkeley. [online]. Available: http://mcb.berkeley.edu/labs/he/Research.htm [April 2014].
44. Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJG, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S,. 2012. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14: 249-256.
45. Heusschen R, van Gink M, Griffioen AW, Thijssen VL,. 2010. MicroRNAs in the tumor endothelium: Novel controls on the angioregulatory switchboard. Biochim Biophys Acta 1805: 87-96.
46. Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg Å, Gradin K, Poellinger L, Påhlman S,. 2006. Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell 10: 413-423.
47. Hong L, Han Y, Zhang H, Zhao Q, Qiao Y,. 2013. MiR-210: A therapeutic target in cancer. Expert Opin Ther Tar 17: 21-28.
48. Hood JL, Pan H, Lanza GM, Wickline SA,. 2009. Paracrine induction of endothelium by tumor exosomes. Lab Invest 89: 1317-1328.
49. Howe E, Cochrane D, Richer J,. 2012. The miR-200 and miR-221/222 microRNA families: Opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia 17: 65-77.
50. Hu C-J, Wang L-Y, Chodosh LA, Keith B, Simon MC,. 2003. Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation. Mol Cell Biol 23: 9361-9374.
51. Hua Z, Lv Q, Ye W, Wong C-KA, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, Zhang Y,. 2006. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: e116.
52. Huang X, Le Q-T, Giaccia AJ,. 2010. MiR-210?micromanager of the hypoxia pathway. Trends Mol Med 16: 230-237.
53. Hulsmans M, De Keyzer D, Holvoet P,. 2011. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 25: 2515-2527.
54. Jain R, 2003. Molecular regulation of vessel maturation. Nat Med 9: 685-693.
55. Jain RK, 2005. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307: 58-62.
56. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ,. 2005. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113: 752-760.
57. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ,. 2005. RAS Is Regulated by the let-7 MicroRNA Family. Cell 120: 635-647.
58. Jusufovic E, Rijavec M, Keser D, Korošec P, Sodja E, Iljazovic E, Radojevic Z, Košnik M,. 2012. Let-7b and miR-126 Are Down-Regulated in Tumor Tissue and Correlate with Microvessel Density and Survival Outcomes in Non-Small-Cell Lung Cancer. PLoS One 7: e45577.
59. Kang SG, Lee WH, Lee YH, Lee YS, Kim SG,. 2012. Hypoxia-inducible factor-1α inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction. Carcinogenesis 33: 661-669.
60. Karreth Florian A, Tay Y, Perna D, Ala U, Tan Shen M, Rust Alistair G, DeNicola G, Webster Kaitlyn A, Weiss D, Perez-Mancera Pedro A, Krauthammer M, Halaban R, Provero P, Adams David J, Tuveson David A, Pandolfi Pier P,. 2011. In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma. Cell 147: 382-395.
61. Khew-Goodall Y, Goodall GJ,. 2012. Stromal miR-320 keeps an oncogenic secretome in check. Nat Cell Biol 14: 124-125.
62. Klagsbrun M, D'Amore PA,. 1991. Regulators of Angiogenesis. Annu Rev of Physiol 53: 217-239.
63. Knuutila S, Björkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y,. 1998. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies. Am J Pathol 152: 1107-1123.
64. Kuehbacher A, Urbich C, Dimmeler S,. 2008. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 29: 12-15.
65. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S,. 2007. Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis. Circ Res 101: 59-68.
66. Kuhnert F, Kuo CJ,. 2010. MiR- 17-92 angiogenesis micromanagement. Blood 115: 4631-4633.
67. Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen C-Z, Kuo CJ,. 2008. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135: 3989-3993.
68. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T,. 2008. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 105: 3903-3908.
69. Lancaster GI, Febbraio MA,. 2005. Exosome-dependent trafficking of HS P70: A novel secretory pathway for cellular stress proteins. J Biol Chem 280: 23349-23355.
70. Le Bot N, 2012. MicroRNAs in angiogenesis. Nat Cell Biol 14: 342-342.
71. Lee DY, Deng Z, Wang CH, Yang BB,. 2007. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 104: 20350-20355.
72. Lee I, Ajay SS, Yook JI, Kim HS, Hong SH, Kim NH, Dhanasekaran SM, Chinnaiyan AM, Athey BD,. 2009. New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res 19: 1175-1183.
73. Li Y-P, Gottwein JM, Scheel TK, Jensen TB, Bukh J,. 2011. MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR. Proc Natl Acad Sci U S A 108: 4991-4996.
74. Ling H, Zhang W, Calin GA,. 2011. Principles of microRNA involvement in human cancers. Chin J Cancer 30: 739-748.
75. Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG,. 2006. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 176: 1375-1385.
76. Liu Y, Deisseroth A,. 2006. Tumor vascular targeting therapy with viral vectors. Blood 107: 3027-3033.
77. Lou Y-L, Guo F, Liu F, Gao F-L, Zhang P-Q, Niu X, Guo S-C, Yin J-H, Wang Y, Deng Z-F,. 2012. MiR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol Cell Biochem 370: 45-51.
78. Lytle JR, Yario TA, Steitz JA,. 2007. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc Natl Acad Sci U S A 104: 9667-9672.
79. MacFarlane L-A, Murphy PR,. 2010. MicroRNA: Biogenesis, function and role in cancer. Curr Genomics 11: 537-561.
80. Melo SA, Kalluri R,. 2012. Molecular pathways: MicroRNAs as cancer therapeutics. Clin Cancer Res 18: 4234-4239.
81. Mendell JT, 2008. MiRiad roles for the miR- 17-92 cluster in development and disease. Cell 133: 217-222.
82. Mulik S, Xu J, Reddy P, Rajasagi N, Gimenez F, Sharma S, Lu P, Rouse B,. 2012. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol 181: 525-534.
83. Muramatsu F, Kidoya H, Naito H, Sakimoto S, Takakura N,. 2012. MicroRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin. Oncogene 32: 414-421.
84. Nicoli S, Knyphausen C-P, Zhu Lihua J, Lakshmanan A, Lawson Nathan D,. 2012. MiR-221 is required for endothelial tip cell behaviors during vascular development. Dev Cell 22: 418-429.
85. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND,. 2010. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464: 1196-1200.
86. Olive V, Jiang I, He L,. 2010. Mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42: 1348-1354.
87. Ørom UA, Nielsen FC, Lund AH,. 2008. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30: 460-471.
88. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M,. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087-3095.
89. Papetti M, Herman IM,. 2002. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282: C947-C970.
90. Park J-K, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, Schmittgen TD,. 2011. MiR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 71: 7608-7616.
91. Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK,. 2010. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 9: 1085-1099.
92. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM,. 2009. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4: 62-72.
93. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G,. 2006. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108: 3068-3071.
94. Quintavalle C, Garofalo M, Croce CM, Condorelli G,. 2011. ApoptomiRs in vascular cells: Their role in physiological and pathological angiogenesis. Vascul Pharmacol 55: 87-91.
95. Roy S, Sen CK,. 2012. MiRNA in wound inflammation and angiogenesis. Microcirculation 19: 224-232.
96. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS,. 2000. Hypoxia-inducible Factor-1α is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015.
97. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K, Kirita T, Kuniyasu H,. 2012. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107: 700-706.
98. Schwarz D, Hutvágner G, Du T, Xu Z, Aronin N, Zamore P,. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208.
99. Sessa R, Seano G, di Blasio L, Gagliardi PA, Isella C, Medico E, Cotelli F, Bussolino F, Primo L,. 2012. The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β. Biochim et Biophys Acta 1823: 1925-1935.
100. Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE, Leek R, Edelmann M, Kessler B, Sainson RCA, Sargent I, Li J-L, Harris AL,. 2010. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 116: 2385-2394.
101. Shi Z-m, Wang J, Yan Z, You Y-p, Li C-y, Qian X, Yin Y, Zhao P, Wang Y-y, Wang X-f, Li M-n, Liu L-Z, Liu N, Jiang B-H,. 2012. MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6 K1. PLoS One 7: e32709.
102. Shilo S, Roy S, Khanna S, Sen CK,. 2008. Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol 28: 471-477.
103. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Jr., Carter BS, Krichevsky AM, Breakefield XO,. 2008. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476.
104. Suárez Y, Fernández-Hernando C, Pober JS, Sessa WC,. 2007. Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells. Circ Res 100: 1164-1173.
105. Sun J, Chen Z, Tan X, Zhou F, Tan F, Gao Y, Sun N, Xu X, Shao K, He J,. 2013. MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Med Oncol 30: 1-9.
106. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S,. 2001. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166: 7309-7318.
107. Urbich C, Kuehbacher A, Dimmeler S,. 2008. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588.
108. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO,. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
109. van Balkom BWM, de Jong OG, Smits M, Brummelman J, den Ouden K, de Bree PM, van Eijndhoven MAJ, Pegtel DM, Stoorvogel W, Würdinger T, Verhaar MC,. 2013. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 121: 3997-4006.
110. Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO, Krichevsky AM,. 2008. MiR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells. Cancer Cell 14: 382-393.
111. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN,. 2008. The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis. Dev Cell 15: 261-271.
112. Wang S, Olson EN,. 2009. AngiomiRs-Key regulators of angiogenesis. Curr Opin Genet Dev 19: 205-211.
113. Yamakuchi M,. 2012. MicroRNAs regulation of tumor angiogenesis. In:, Ran Sophia, editor. Tumor angiogenesis. InTech. p. 231-48.
114. Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, Huso D, Lowenstein CJ,. 2010. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A 107: 6334-6339.
115. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu C-G, Croce CM, Harris CC,. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
116. Yang W, Wei J, Sun T, Liu F,. 2013. Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice. Radiat Oncol 8: 102.
117. Ye P, Liu J, He F, Xu W, Yao K,. 2014. Hypoxia-Induced Deregulation of miR-126 and Its Regulative Effect on VEGF and MMP-9 Expression. Int J Med Sci 11: 17-23.
118. Yin R, Bao W, Xing Y, Xi T, Gou S,. 2012. MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells. Biochem Bioph Res Co 417: 771-776.
119. Yin R, Wang R, Guo L, Zhang W, Lu Y,. 2013. MiR-17-3p Inhibits Angiogenesis by Downregulating Flk-1 in the Cell Growth Signal Pathway. J Vas Res 50: 157-166.
120. Zamore PD, Haley B,. 2005. Ribo-gnome: the big world of small RNAs. Science 309: 1519-1524.
121. Zhan R, Leng X, Liu X, Wang X, Gong J, Yan L, Wang L, Wang Y, Wang X, Qian L-J,. 2009. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. Biochem Bioph Res Co 387: 229-233.
122. Zhang Q, Kandic I, Kutryk MJ,. 2011. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem Bioph Res Co 405: 42-46.
123. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q, Wang K, Ba Y, Wang Q, Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K, Zhang C-Y,. 2010. Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration. Mol Cell 39: 133-144.
124. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S,. 2011. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. Proc Natl Acad Sci U S A 108: 8287-8292.